1. Medtech Insight
  2. >>Device Area
  3. >>Cardiology

EuroPCR 2018: Robocath Eyes December CE Mark For R-One Positive Pre-Clin Data

 
• By Tina Tan

Robocath is planning a year-end market launch of its flagship R-One robotic catheterization system after the preclinical trial of R-One hit all primary endpoints. If the product is CE-marked in December as anticipated, it will be a rival to Corindus Vascular's CorPath, which is currently the only robotic-assisted system in the market for interventional cardiology. Robocath announced the preclinical data at EuroPCR in Paris, being held this week until May 25.

Robocath
• Source: Source: Robocath

Robocath's R-One system is expected to be the second robot-assisted system on the market designed specifically for interventional cardiology procedures, as the company plans on getting a CE mark and hitting the European and Middle Eastern markets by the end of the year. The launch comes on the back of positive data from a preclinical study – announced May 22 at this year's EuroPCR meeting in Paris – which showed that the technology met all its primary efficacy and safety endpoints.

The French firm first unveiled R-One at last year's EuroPCR, where it announced it had raised €4.7m from various investors...

More from Cardiology

More from Device Area

Ultrahuman Launches Home Health Monitoring

 
• By Natasha Barrow

Ultrahuman seeks to “create an environment that aligns with our bodies" by linking environmental parameters collected by Ultrahuman Home to health physiology, measured by the Ultrahuman Ring Air.

HistoSonics’ Edison System Gains Limited UK Access, While Awaiting CE Marking

 
• By Shubham Singh

While HistoSonics is awaiting the CE mark in Europe, it hit a major milestone by securing early limited market access in Great Britain under a Unmet Clinical Need Authorization (UCNA), bringing its noninvasive histotripsy treatment to patients with liver tumors.

Johnson & Johnson MedTech: How To Scale Digital Solutions

 
• By Natasha Barrow

J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.